Quick Answer
IDEAYA Biosciences, Inc. reported Stockholders Equity of $1.02 billion for fiscal year 2025.
IDEAYA Biosciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.02B | -3.4% |
| 2024 | $1.06B | +70.5% |
| 2023 | $621.09M | +77.7% |
| 2022 | $349.45M | +15.9% |
| 2021 | $301.51M | +52.1% |
| 2020 | $198.27M | +97.5% |
| 2019 | $100.40M | +305.1% |
| 2018 | -$48.95M | -211.0% |
| 2017 | -$15.74M | -280.9% |
| 2016 | -$4.13M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.09B | -7.5% | +13.8% |
| June 30, 2025 | $959.65M | +3.0% | -6.3% |
| March 31, 2025 | $1.02B | +9.5% | -3.3% |
| December 31, 2024 | $1.06B | +70.5% | -10.3% |
| September 30, 2024 | $1.18B | +132.3% | +26.7% |
| June 30, 2024 | $931.66M | +85.7% | -0.4% |
| March 31, 2024 | $935.31M | +180.2% | +50.6% |
| December 31, 2023 | $621.09M | +77.7% | +22.3% |
- IDEAYA Biosciences, Inc. showed a decrease of -3.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, IDEAYA Biosciences, Inc.’s stockholders equity has grown by 24856.4% (from -$4.13 million to $1.02 billion).
- The most recent figure is from IDEAYA Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: